Resources for Pharmacists

Naloxone | Screening | CSRS

The goal of this brief video series is to reduce the potential for negative effects from the nonmedical use of opioids. Dr. Kimberly Sanders, a clinical pharmacist who specializes in pharmacy practice and medication management in dental settings provides an overview of risk mitigation strategies for opioid prescribing including closer looks at prescription drug monitoring programs, optimal patient communication practices, medication consideration for safe treatment, naloxone co-prescribing, safe storage and disposal.

Risk mitigation strategies for opioid prescribing stewardship are noted as ways to reduce risk of adverse outcomes of addiction, unintentional overdose, and death that could result from inappropriate prescribing or misuse of opioids.

This brief video discusses the role pharmacists can play in responding to the opioid crisis by increasing access to naloxone. As you may know, naloxone is an opioid antagonist that is administered both by laypersons and health professionals in emergency situations to reverse the effects of an opioid overdose.

Pharmacists can play an important role in identifying patients who may be at higher risk for an opioid overdose. In this video, Dr. Viracola shares two strategies you can use to help identify your patients at the highest risk for opioid overdose and misuse. These strategies include the revised Overdose Risk Tool (ORT-R) and the Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression (RIOSORD).  

Learn more about our conferences and educational opportunities

Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.